Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications

Hugo Felix Perini; Beatriz Sodré Matos; Carlo José Freire de Oliveira; Marcos Vinicius da Silva

doi:10.3762/bjnano.15.127

Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications

Beilstein J Nanotechnol. 2024 Dec 16:15:1619-1626. doi: 10.3762/bjnano.15.127. eCollection 2024.

Authors

Hugo Felix Perini^#¹, Beatriz Sodré Matos^#¹, Carlo José Freire de Oliveira¹, Marcos Vinicius da Silva¹

Affiliation

¹ Department of Immunology, Microbiology and Parasitology. Biological and Natural Sciences Institute. Federal University of Triângulo Mineiro. Uberaba, Minas Gerais, Brazil.

^# Contributed equally.

Abstract

Biomimetic nanocarriers, engineered to mimic the characteristics of native cells, offer a revolutionary approach in the treatment of various complex human diseases. This strategy enhances drug delivery by leveraging the innate properties of cellular components, thereby improving biocompatibility and targeting specificity. Biomimetic nanocarriers demonstrate significant advancements in drug delivery systems against cancer therapy, Alzheimer's disease, autoimmune diseases, and viral infections such as COVID-19. Here, we address the therapeutic applications of biomimetic nanocarriers and their promising strategy for personalized medicine.

Keywords: cancer; drug delivery; human health; mimetics; nanotechnology.

Grants and funding

This work was supported by the Fundação de Amparo à Pesquisa do Estado Minas Gerais (FAPEMIG – funding number: RED-00198-23 and RED-00224-23) and by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq Bench fee Lv2).